{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:15:39Z","timestamp":1781025339215,"version":"3.54.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"DOI":"10.7759\/cureus.54751","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:30:27Z","timestamp":1708691427000},"source":"Crossref","is-referenced-by-count":2,"title":["Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Christeebella","family":"Akpala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Comparison of guidelines for the use of interleukin-17 inhibitors for psoriasis in the United States, Britain, and Europe: a critical appraisal and comprehensive review","volume":"14","author":"Kearns DG","year":"2021","unstructured":"Kearns DG, Uppal S, Chat VS, Wu JJ. Comparison of guidelines for the use of interleukin-17 inhibitors for psoriasis in the United States, Britain, and Europe: a critical appraisal and comprehensive review. J Clin Aesthet Dermatol. 2021, 14:55-9.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref2","article-title":"Alopecia areata","author":"Lepe K","year":"2023","unstructured":"Lepe K, Syed HA, Zito PM. Alopecia areata. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123397","article-title":"The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications","volume":"10","author":"Wa\u015bkiel-Burnat A","year":"2021","unstructured":"Wa\u015bkiel-Burnat A, Osi\u0144ska M, Sali\u0144ska A, Blicharz L, Goldust M, Olszewska M, Rudnicka L. The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications. Cells. 2021, 10:3397. 10.3390\/cells10123397","journal-title":"Cells"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1823-y","article-title":"IL-17 inhibition: is it the long-awaited savior for alopecia areata?","volume":"310","author":"Ramot Y","year":"2018","unstructured":"Ramot Y, Marzani B, Pinto D, Sorbellini E, Rinaldi F. IL-17 inhibition: is it the long-awaited savior for alopecia areata?. Arch Dermatol Res. 2018, 310:383-90. 10.1007\/s00403-018-1823-y","journal-title":"Arch Dermatol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky E","year":"2018","unstructured":"Guttman-Yassky E, Nia JK, Hashim PW, et al.. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata. Arch Dermatol Res. 2018, 310:607-14. 10.1007\/s00403-018-1853-5","journal-title":"Arch Dermatol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000499030","article-title":"Alopecia diffusa while using interleukin-17 inhibitors against psoriasis vulgaris","volume":"11","author":"Yajima M","year":"2019","unstructured":"Yajima M, Akeda T, Kondo M, Habe K, Yamanaka K. Alopecia diffusa while using interleukin-17 inhibitors against psoriasis vulgaris. Case Rep Dermatol. 2019, 11:82-5. 10.1159\/000499030","journal-title":"Case Rep Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38986","article-title":"Alopecia areata after initiation of secukinumab therapy for plaque psoriasis","volume":"15","author":"Choi E","year":"2023","unstructured":"Choi E, Thomson O, Smith D. Alopecia areata after initiation of secukinumab therapy for plaque psoriasis. Cureus. 2023, 15:e38986. 10.7759\/cureus.38986","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.10.012","article-title":"Ixekizumab-induced alopecia areata","volume":"6","author":"Eldirany SA","year":"2020","unstructured":"Eldirany SA, Myung P, Bunick CG. Ixekizumab-induced alopecia areata. JAAD Case Rep. 2020, 6:51-3. 10.1016\/j.jdcr.2019.10.012","journal-title":"JAAD Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2011.01.047","article-title":"[Alopecia areata during anti-TNF alpha therapy: nine cases]","volume":"138","author":"Le Bidre E","year":"2011","unstructured":"Le Bidre E, Chaby G, Martin L, et al.. [Alopecia areata during anti-TNF alpha therapy: nine cases]. Ann Dermatol Venereol. 2011, 138:285-93. 10.1016\/j.annder.2011.01.047","journal-title":"Ann Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/232549-ophiasis-alopecia-areata-in-a-patient-with-spondyloarthritis-on-secukinumab-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:30:29Z","timestamp":1708691429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/232549-ophiasis-alopecia-areata-in-a-patient-with-spondyloarthritis-on-secukinumab-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.54751","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}